| http://www.w3.org/ns/prov#value | - Herceptin (Trastuzumab), which binds to these proteins, blocks these cells from obtaining the nutrients they need to thrive, and in combination with other therapies, including chemotherapy or surgery, can dramatically reduce the recurrence rate of additional cancers.
|
